CARES:A Prospective, Phase IV, Open-Label, Non-Randomiozed, Multicenter, Surveillance REgistry Study to Evaluate the Safety of DEFINITY in Clinical Practice

ID Number 08-1284

Principal Investigator(s)
Martin E Goldman

Department(s) or Division(s)
Cardiology

Description

The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®. DEFINITY is a contrast agent that is used during echocardiogram measurements of the heart. ClinicalTrials.gov Identifier: NCT00625365



Contact Information
Ida Guzman
Ida.Guzman@mountsinai.org


Recruiting Patients: No